QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

This Article
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (13)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Neumann, P. J.
* Articles by Weinstein, M. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Neumann, P. J.
* Articles by Weinstein, M. C.
Related Collections
* Legal/Regulatory Issues
* Pharmaceuticals
* Research And Technology
Health Affairs, Vol 19, Issue 5, 129-137
Copyright © 2000 by Project HOPE


Health Tracking

The FDA's regulation of health economic information

P J Neumann, K Claxton, and M C Weinstein

Section 114 of the Food and Drug Administration Modernization Act of 1997 was intended to increase the flow of health economic information from pharmaceutical manufacturers to managed care decisionmakers. But the legislation raises a host of complex questions and has provoked diverse opinions from inside and outside the pharmaceutical industry. Moreover, the Food and Drug Administration (FDA) has yet to issue interpretative guidance on the subject. The challenge in implementing Section 114 lies in developing a policy that improves health economic information exchange while protecting consumers from misleading claims and preserving incentives for manufacturers to conduct rigorous studies.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
P. J. Neumann
Emerging Lessons From The Drug Effectiveness Review Project
Health Aff., July 1, 2006; 25(4): W262 - W271.
[Abstract] [Full Text] [PDF]


Home page
Social Studies of ScienceHome page
P. Mirowski and R. Van Horn
The Contract Research Organization and the Commercialization of Scientific Research
Social Studies of Science, August 1, 2005; 35(4): 503 - 548.
[Abstract] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2000 Project HOPE–The People-to-People Organization
Terms and Policies